Mr. Anthony Poggio, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2059 Clinton Ave, Alameda, CA 94501 Phone: 510-521-2568 |
Dr. Randolph Terry Wright, D.P.M. Podiatrist - Primary Podiatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 S Shore Ctr W Ste 103e, Alameda, CA 94501 Phone: 510-521-0441 Fax: 510-521-7473 |
Bay Area Foot Care Podiatrist Medicare: Medicare Enrolled Practice Location: 2059 Clinton Ave Ste 1, Alameda, CA 94501 Phone: 510-521-2568 Fax: 510-521-9610 |
Mr. Ted Francis Mihok, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2059 Clinton Ave, Alameda, CA 94501 Phone: 510-865-2500 |
Jeffrey Joseph Niccoli, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 2225 Central Ave, Alameda, CA 94501 Phone: 510-521-3410 Fax: 510-521-2521 |
Dr. Dale R Wright V, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 501 S Shore Center W 103e, Alameda, CA 94501 Phone: 510-521-0441 Fax: 510-521-7473 |
Acc Podiatry Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2059 Clinton Ave Ste 1, Alameda, CA 94501 Phone: 510-521-2568 |
Jennifer P Strauser, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 2059 Clinton Ave, Ste 1, Alameda, CA 94501 Phone: 510-521-2568 |
Acc Podiatry, A Podiatric Corporation Podiatrist Medicare: Medicare Enrolled Practice Location: 2059 Clinton Ave Ste 1, Alameda, CA 94501 Phone: 510-521-2568 |
News Archive
Eugene Allen, a retired police officer and teacher from Sicklerville, N.J., had a decision to make in February, after an MRI revealed a precancerous cyst in his pancreas. It had to be removed, but the question was how?
A corporate blog post by the company's human resources chief cited the health plans now available on public health exchanges as part of Target's decision, as well as the fact that only about 10 percent of its estimated 360,000 employees participated in the plan that is being discontinued. Those workers will be given $500 because their current coverage is ending.
Ligand Pharmaceuticals Incorporated today announced it has been awarded $1,955,834 in immediately available funds from the U.S. government under HR: 3590 - Patient Protection and Affordable Care Act. The award comprises separate payments of approximately $245,000 for each of eight drug development programs at Ligand.
Patients whose anxiety intensified over time were in greatest peril, while those who started out highly anxious but later found inner calm markedly reduced their risk. The research appears in the May 22, 2007 issue of the Journal of the American College of Cardiology (JACC).
› Verified 9 days ago